Zimmer Biomet is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues.

Employee Rating

3.2More
TypePublic
HQWarsaw, US
Founded1927
Size (employees)18,200 (est)-1%
Websitezimmerbiomet.com
Zimmer Biomet was founded in 1927 and is headquartered in Warsaw, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Zimmer Biomet

Bryan Hanson

Bryan Hanson

President and Chief Executive Officer
Aure Bruneau

Aure Bruneau

Group President, Spine, CMF, Thoracic and Surgery Assisting Technology
Chad Phipps

Chad Phipps

Senior Vice President, General Counsel and Secretary
Daniel Williamson

Daniel Williamson

Group President, Joint Reconstruction
Sang Yi

Sang Yi

President, Asia Pacific
Tony Collins

Tony Collins

Vice President, Corporate Controller and Chief Accounting Officer
Show more

Zimmer Biomet Office Locations

Zimmer Biomet has an office in Warsaw
Warsaw, US (HQ)
345 E Main St
Warsaw, US
1800 W Center St
Show all (2)
Report incorrect company information

Zimmer Biomet Financials and Metrics

Zimmer Biomet Revenue

Embed Graph
View revenue for all periods
Zimmer Biomet's revenue was reported to be $7.68 b in FY, 2016 which is a 28.1% increase from the previous period.
USD

EBIT (Q2, 2018)

296.0m

Market capitalization (16-Jan-2019)

21.4b

Closing stock price (16-Jan-2019)

105.0
Zimmer Biomet's current market capitalization is $21.4 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

4.6b4.7b6.0b7.7b

Revenue growth, %

1%28%28%

Cost of goods sold

1.3b1.2b1.8b2.4b

Gross profit

3.3b3.4b4.2b5.3b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

1.1b1.2b1.2b1.1b1.1b1.2b176.2m1.9b1.9b1.8b2.0b2.0b1.8b

Cost of goods sold

328.8m305.4m333.2m298.3m278.7m290.5m552.1m635.2m640.1m479.3m512.9m527.7m

Gross profit

745.5m856.1m849.7m807.7m855.7m877.1m(375.9m)1.3b1.3b1.4b1.5b1.4b

Gross profit Margin, %

69%74%72%73%75%75%(213%)67%67%74%74%73%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

1.1b1.1b1.5b634.1m

Accounts Receivable

936.6m912.1m1.4b1.6b

Prepaid Expenses

107.1m193.7m538.4m465.7m

Inventories

1.1b1.2b2.3b2.0b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

8.8b450.0m

Accounts Receivable

869.8m1.5b1.4b1.6b1.6b1.6b1.6b1.4b

Prepaid Expenses

246.8m551.7m475.8m420.7m518.9m535.8m463.3m527.2m

Inventories

1.2b2.1b2.0b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

759.2m719.0m146.2m304.6m

Depreciation and Amortization

358.5m375.8m712.4m1.0b

Inventories

(128.4m)(154.1m)(205.4m)76.4m

Accounts Payable

38.3m120.1m(263.1m)28.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018

Net Income

176.1m176.8m18.6m19.5m105.8m77.0m483.4m98.8m

Depreciation and Amortization

101.0m89.0m188.6m428.1m246.9m531.7m

Inventories

(62.2m)(149.9m)(196.5m)38.3m(68.8m)2.1b

Accounts Payable

(56.0m)(149.5m)95.8m(251.5m)(120.7m)(76.0m)(137.0m)(203.7m)327.1m
USDY, 2018

Financial Leverage

2.1 x
Show all financial metrics

Zimmer Biomet Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017

Countries

100 100 100 100

Patents and Patent Applications

4.50 k7 k8 k8 k
Show all operating metrics

Zimmer Biomet Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Accelero Health Partners
Aut Inveniam Aut Faciam Pty. Ltd.
Beijing Montagne Medical Device Co. Ltd.
Biomet
Biomet 3i
Biomet 3i Australia Pty. Ltd.
Biomet 3i Belgium N.V.
Biomet 3i Benelux Holdings N.V.
Biomet 3i do Brasil Comercio de Aparelhos Medicos Ltda.
Biomet 3i Portugal Lda
Show more

Zimmer Biomet Revenue Breakdown

Embed Graph

Zimmer Biomet revenue breakdown by business segment: 8.6% from Spine & CMF, 5.6% from Dental, 21.4% from S.E.T, 24.3% from Hips, 35.8% from Knees and 4.3% from Other

Report incorrect company information

Zimmer Biomet Online and Social Media Presence

Embed Graph
Report incorrect company information

Zimmer Biomet News and Updates

Global $2.9 Bn Hydroxyapatite Market to 2023: Investments by Major Players like Zimmer Biomet, Johnson & Johnson and Medtronic to Positively Influence the Market

DUBLIN, Jan. 17, 2019 /PRNewswire/ -- The "Global Hydroxyapatite Market By Type (Nano-sized, Micro-sized and Greater than Micrometer), By Application (Orthopedic, Plastic Surgery, Dental Care and Others), By Region, Competition, Forecast & Opportunities, 2013-2023" report has been added...

Spinal Implants and Surgical Devices Global Market 2019: Key Players – DePuy Synthes, Stryker Corporation, NuVasive, Zimmer Biomet, Globus Medical

Wiseguyreports.Com adds “Spinal Implants and Surgical Devices Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

The impact analysis of Global Spinal Implants and Devices Market 2025 with innovations, new developments, marketing strategies adopted by the established players such as Orthotic International N.V., Stryker Corporation, and Zimmer Biomet Holdings, Inc.

Different dynamic aspects of the businesses have been examined, which are responsible for driving or restraining the growth of the companies. R Posted via Industry Today. Follow us on Twitter @IndustryToday

Surgical Drills Market to Grow at CAGR of +4% – Report Studied Growing Factors Forecasts to 2023 – Stryker Corporation, Zimmer Biomet Holdings, Medtronic plc, DePuy Synthes, CONMED Corporation

surgical drills market is expanding significantly due to a rise in number of surgical procedures and increase in prevalence of chronic diseases that require surgical procedures. Posted via Industry Today. Follow us on Twitter @IndustryToday

Bone Cements Market Key Players Competitive & Comparative Analysis, Growth Till 2023|Stryker, Zimmer Biomet (Heraeus Medical), DePuy Synthes (Johnson & Johnson)

Bone Cements Market Report aims to define, describe, and forecast on the basis of Market size, share, types, overview, top key vendors. This research report provides analysis and information according to market segments such as geography, technology and application. Posted via Industry Today. Follow…

Zimmer Biomet to Present at 37th Annual J.P. Morgan Healthcare Conference

WARSAW, Ind., Dec. 18, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Tuesday,...
Show more
Report incorrect company information

Zimmer Biomet Company Life and Culture

Report incorrect company information

Zimmer Biomet Frequently Asked Questions

  • When was Zimmer Biomet founded?

    Zimmer Biomet was founded in 1927.

  • Who are Zimmer Biomet key executives?

    Zimmer Biomet's key executives are Bryan Hanson, Aure Bruneau and Chad Phipps.

  • How many employees does Zimmer Biomet have?

    Zimmer Biomet has 18,200 employees.

  • What is Zimmer Biomet revenue?

    Latest Zimmer Biomet annual revenue is $7.7 b.

  • What is Zimmer Biomet revenue per employee?

    Latest Zimmer Biomet revenue per employee is $422.2 k.

  • Who are Zimmer Biomet competitors?

    Competitors of Zimmer Biomet include Dentsply Sirona, Becton Dickinson and Medtronic.

  • Where is Zimmer Biomet headquarters?

    Zimmer Biomet headquarters is located at 345 E Main St, Warsaw.

  • Where are Zimmer Biomet offices?

    Zimmer Biomet has an office in Warsaw.

  • How many offices does Zimmer Biomet have?

    Zimmer Biomet has 2 offices.